Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
AVACOR®, PREMIER PROVIDER OF HAIR GROWTH SOLUTIONS, ACQUIRED BY INVESTOR GROUP. AGGRESSIVE EFFORT AGAINST ROGAINE. Avacor Products LLC (http://www.avacor.com) has acquired the assets of Global Vision Products, Inc., including, the Avacor® brand name; Avacor’s FDA approved Physicians’ Topical Formulation®; the All-Natural Nutricap and Boost! by Avacor®; as well as an ANDA (Abbreviated New Drug Application) which allows the company to market and sell the FDA approved Avacor Physicians’ Formulation®. Brett Levine, CEO of Avacor Products LLC, states that customers will now be afforded significant price savings as well as improved product offerings as a result of specific company specific initiatives. Since the acquisition on January 1, 2009, Avacor Products LLC has been working diligently to build a solid infrastructure. An entirely new, customer centric management team is in place. That team is implementing stricter product quality controls and is developing more efficient order processing and fulfillment procedures. The company now employs a core group of dedicated, receptive, knowledgeable, experienced and better trained customer service agents. New product development is also a part of the strategy, and the company has already begun to deliver some of its new or improved offerings, such as the Nutricap product with the addition of Keratin, an allnatural protein that promotes a healthier scalp and hair follicle. Avacor Products LLC is preparing to launch an aggressive advertising and marketing campaign which includes a new easy-to-use website, updated and more user friendly packaging as well as enhanced customer service. For more information please visit http://www.avacor.com or call 866.946.1830 Avacor Products LLC 227 East 56 Street, 3 Floor | New York, NY 10022 | Office: (212)991‐7100 | Fax: (212)446‐0060 th rd